These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Kulkarni RN; Holzenberger M; Shih DQ; Ozcan U; Stoffel M; Magnuson MA; Kahn CR Nat Genet; 2002 May; 31(1):111-5. PubMed ID: 11923875 [TBL] [Abstract][Full Text] [Related]
6. Distinct and overlapping functions of insulin and IGF-I receptors. Nakae J; Kido Y; Accili D Endocr Rev; 2001 Dec; 22(6):818-35. PubMed ID: 11739335 [TBL] [Abstract][Full Text] [Related]
7. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells. Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066 [TBL] [Abstract][Full Text] [Related]
8. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Fernández AM; Kim JK; Yakar S; Dupont J; Hernandez-Sanchez C; Castle AL; Filmore J; Shulman GI; Le Roith D Genes Dev; 2001 Aug; 15(15):1926-34. PubMed ID: 11485987 [TBL] [Abstract][Full Text] [Related]
9. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes. Casellas A; Salavert A; Agudo J; Ayuso E; Jimenez V; Moya M; Muñoz S; Franckhauser S; Bosch F Diabetes; 2006 Dec; 55(12):3246-55. PubMed ID: 17130467 [TBL] [Abstract][Full Text] [Related]
10. A general and islet cell-enriched overexpression of IGF-I results in normal islet cell growth, hypoglycemia, and significant resistance to experimental diabetes. Robertson K; Lu Y; De Jesus K; Li B; Su Q; Lund PK; Liu JL Am J Physiol Endocrinol Metab; 2008 May; 294(5):E928-38. PubMed ID: 18270301 [TBL] [Abstract][Full Text] [Related]
11. Molecular insights into insulin action and secretion. Rhodes CJ; White MF Eur J Clin Invest; 2002 Jun; 32 Suppl 3():3-13. PubMed ID: 12028370 [TBL] [Abstract][Full Text] [Related]
12. Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? Lingohr MK; Buettner R; Rhodes CJ Trends Mol Med; 2002 Aug; 8(8):375-84. PubMed ID: 12127723 [TBL] [Abstract][Full Text] [Related]
13. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Otani K; Kulkarni RN; Baldwin AC; Krutzfeldt J; Ueki K; Stoffel M; Kahn CR; Polonsky KS Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E41-9. PubMed ID: 14519599 [TBL] [Abstract][Full Text] [Related]
14. Tissue-specific targeting of the insulin receptor gene. Kulkarni RN; Okada T Endocrine; 2002 Dec; 19(3):257-66. PubMed ID: 12624425 [TBL] [Abstract][Full Text] [Related]
15. Beta-Cell hyperplasia induced by hepatic insulin resistance: role of a liver-pancreas endocrine axis through insulin receptor A isoform. Escribano O; Guillén C; Nevado C; Gómez-Hernández A; Kahn CR; Benito M Diabetes; 2009 Apr; 58(4):820-8. PubMed ID: 19136656 [TBL] [Abstract][Full Text] [Related]
16. Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. Bernal-Mizrachi E; Fatrai S; Johnson JD; Ohsugi M; Otani K; Han Z; Polonsky KS; Permutt MA J Clin Invest; 2004 Oct; 114(7):928-36. PubMed ID: 15467831 [TBL] [Abstract][Full Text] [Related]
17. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines. Freund GG; Kulas DT; Way BA; Mooney RA Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537 [TBL] [Abstract][Full Text] [Related]
20. The role of insulin and insulin-like growth factor-I in mammalian ageing. Richardson A; Liu F; Adamo ML; Van Remmen H; Nelson JF Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):393-406. PubMed ID: 15261845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]